Save your place

Sign in to WhoBought

Please try again later.

vTv Therapeutics Inc. (VTVT) institutional ownership

Latest close $31.66 Jul 23, 2026
Market cap$52M 52-week range SectorHealthcare
Funds holding · Q4 2023
23
reported VTVT position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q4 2023
Activity unavailable N/A
0 buyers · 23 sellers

vTv Therapeutics Inc. (VTVT) price and institutional activity

Dates

Q4 2023

$0 bought by 0 investors
$0 sold by 23 investors
Samsara Biocapital, LLCVanguard +21 more
Bought Sold Totals per quarter; hover a bar for the names.

vTv Therapeutics Inc. (VTVT) institutional activity · 23

Investor Type Est. change Change Δ Own Date
Samsara Biocapital, LLC · Exited
Change −1.6M Δ Own −100.0% Date Q4 2023
Samsara Biocapital, LLC Exited· Q4 2023 −1.6M −100.0% Q4 2023
Vanguard · Exited
Change −940K Δ Own −100.0% Date Q4 2023
Vanguard Exited· Q4 2023 −940K −100.0% Q4 2023
Geode · Exited
Change −236K Δ Own −100.0% Date Q4 2023
Geode Exited· Q4 2023 −236K −100.0% Q4 2023
State Street · Exited
Change −135K Δ Own −100.0% Date Q4 2023
State Street Exited· Q4 2023 −135K −100.0% Q4 2023
BlackRock · Exited
Change −54K Δ Own −100.0% Date Q4 2023
BlackRock Exited· Q4 2023 −54K −100.0% Q4 2023
Northern Trust · Exited
Change −50K Δ Own −100.0% Date Q4 2023
Northern Trust Exited· Q4 2023 −50K −100.0% Q4 2023
Morgan Stanley · Exited
Change −33K Δ Own −100.0% Date Q4 2023
Morgan Stanley Exited· Q4 2023 −33K −100.0% Q4 2023
Two Sigma Securities, LLC · Exited
Change −30K Δ Own −100.0% Date Q4 2023
Two Sigma Securities, LLC Exited· Q4 2023 −30K −100.0% Q4 2023
Simon Quick Advisors, LLC · Exited
Change −30K Δ Own −100.0% Date Q4 2023
Simon Quick Advisors, LLC Exited· Q4 2023 −30K −100.0% Q4 2023
Susquehanna International Group, LLP · Exited
Change −20K Δ Own −100.0% Date Q4 2023
Susquehanna International Group, LLP Exited· Q4 2023 −20K −100.0% Q4 2023
Millennium Management LLC · Exited
Change −11K Δ Own −100.0% Date Q4 2023
Millennium Management LLC Exited· Q4 2023 −11K −100.0% Q4 2023
Focused Wealth Management, Inc · Exited
Change −10K Δ Own −100.0% Date Q4 2023
Focused Wealth Management, Inc Exited· Q4 2023 −10K −100.0% Q4 2023
Strengthening Families & Communities, LLC · Exited
Change −7K Δ Own −100.0% Date Q4 2023
Strengthening Families & Communities, LLC Exited· Q4 2023 −7K −100.0% Q4 2023
Osaic Holdings, Inc. · Exited
Change −4K Δ Own −100.0% Date Q4 2023
Osaic Holdings, Inc. Exited· Q4 2023 −4K −100.0% Q4 2023
Parallel Advisors, LLC · Exited
Change −2K Δ Own −100.0% Date Q4 2023
Parallel Advisors, LLC Exited· Q4 2023 −2K −100.0% Q4 2023
Data through Q4 2023 · filed Q4 2023
15 of 23

Famous investor activity in vTv Therapeutics Inc. (VTVT)

vTv Therapeutics Inc. (VTVT) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Baker Bros. Advisors LP · Director 2 operations 12K
Owned 6K Trade date Jun 26, 2026 Filed date Jun 29, 2026
Baker Bros. Advisors LP Director 2 operations 12K 6K Jun 26, 2026 Jun 29, 2026
Spiegelman Daniel K. · Director Grant (A) $210K
Price $35.08 Qty 6K Owned 16K Trade date Jun 26, 2026 Filed date Jun 29, 2026
Spiegelman Daniel K. Director Grant (A) $35.08 6K $210K 16K Jun 26, 2026 Jun 29, 2026
Akkaraju Srinivas · Director Grant (A) $210K
Price $35.08 Qty 6K Owned 17K Trade date Jun 26, 2026 Filed date Jun 29, 2026
Akkaraju Srinivas Director Grant (A) $35.08 6K $210K 17K Jun 26, 2026 Jun 29, 2026
Al-Marzooqi Fahed · Director Grant (A) $210K
Price $35.08 Qty 6K Owned 20K Trade date Jun 26, 2026 Filed date Jun 29, 2026
Al-Marzooqi Fahed Director Grant (A) $35.08 6K $210K 20K Jun 26, 2026 Jun 29, 2026
Phillips Anne M. · Director Grant (A) $210K
Price $35.08 Qty 6K Owned 17K Trade date Jun 26, 2026 Filed date Jun 29, 2026
Phillips Anne M. Director Grant (A) $35.08 6K $210K 17K Jun 26, 2026 Jun 29, 2026
Tung Michael Stephen · Officer Grant (A) $1.7M
Price $36.92 Qty 45K Owned 90K Trade date Feb 17, 2026 Filed date Feb 18, 2026
Tung Michael Stephen Officer Grant (A) $36.92 45K $1.7M 90K Feb 17, 2026 Feb 18, 2026
Sekhri Paul J. · Director, Officer Grant (A) $5.2M
Price $36.92 Qty 140K Owned 392K Trade date Feb 17, 2026 Filed date Feb 18, 2026
Sekhri Paul J. Director, Officer Grant (A) $36.92 140K $5.2M 392K Feb 17, 2026 Feb 18, 2026
Akkaraju Srinivas · Director 3 operations 2.0M
Price $15.27 Owned 983K Trade date Sep 22, 2025 Filed date Sep 25, 2025
Akkaraju Srinivas Director 3 operations $15.27 2.0M 983K Sep 22, 2025 Sep 25, 2025
Akkaraju Srinivas · Director 2 operations 1.3M
Owned 656K Trade date Sep 3, 2025 Filed date Sep 5, 2025
Akkaraju Srinivas Director 2 operations 1.3M 656K Sep 3, 2025 Sep 5, 2025
Baker Julian · Director 6 operations 5.2M
Owned 472K Trade date Sep 3, 2025 Filed date Sep 5, 2025
Baker Julian Director 6 operations 5.2M 472K Sep 3, 2025 Sep 5, 2025
10 of 10

vTv Therapeutics Inc. (VTVT) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Macandrews & Forbes Inc. 61.5M
% of shares outstanding 67.0% Filing date Nov 12, 2021
Macandrews & Forbes Inc. 61.5M 67.0% Nov 12, 2021
Trails Edge Capital Partners, LP 341K
% of shares outstanding 9.9% Filing date Sep 8, 2025
Trails Edge Capital Partners, LP 341K 9.9% Sep 8, 2025
Invus Public Equities, L.P. 346K
% of shares outstanding 8.4% Filing date Nov 12, 2025
Invus Public Equities, L.P. 346K 8.4% Nov 12, 2025
3 of 3

vTv Therapeutics Inc. (VTVT) ownership FAQ

Who owns VTVT?

23 reporting institutions disclosed VTVT position changes in the Q4 2023 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q4 2023.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.